Dynavax Technologies Corp. (DVAX)

17.75
NASDAQ : Health Technology
Prev Close 17.35
Day Low/High 17.20 / 18.10
52 Wk Low/High 3.95 / 24.45
Avg Volume 1.31M
Exchange NASDAQ
Shares Outstanding 60.60M
Market Cap 1.05B
EPS -2.90
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Watch These Biotechs and the FDA Calendar

Watch These Biotechs and the FDA Calendar

Here are a few key events I will be watching closely for in the months ahead on stocks I think are buys at current levels.

3 Key Biotech Catalysts on the FDA Calendar

3 Key Biotech Catalysts on the FDA Calendar

A roundup of biotech names with actions pending at the FDA in coming weeks.

Dynavax Announces HEPLISAV-B™ Is Now Available In The United States For The Prevention Of Hepatitis B In Adults

Dynavax Announces HEPLISAV-B™ Is Now Available In The United States For The Prevention Of Hepatitis B In Adults

HEPLISAV-B is the First and Only Two-Dose Vaccine in U.S. for Hepatitis B Prevention in Adults

5 Small Biotechs Receive Shots in the Arm

5 Small Biotechs Receive Shots in the Arm

Favorable quarterly results and FDA drug approvals should help lift these five names.

5 Small Biotechs Receive Shots in the Arm

5 Small Biotechs Receive Shots in the Arm

Favorable quarterly results and FDA drug approvals should help lift these five names.

Acadia, Dynavax Make the Biotech Mailbag

Acadia, Dynavax Make the Biotech Mailbag

Readers have asked about Acadia Pharmaceuticals and Dynavax Technologies, so we answer.

These 4 Small Biotechs Have Big Upcoming Catalysts

These 4 Small Biotechs Have Big Upcoming Catalysts

Zogenix, Flexion, Dynavax and Progenics all have potential upside on these events.

4 Small Biotechs With Big Catalysts

4 Small Biotechs With Big Catalysts

Zogenix, Flexion, Dynavax and Progenics all have potential upside on upcoming events.

Federman & Sherwood Announces Settlement In Dynavax Shareholder Derivative Action

Federman & Sherwood Announces Settlement In Dynavax Shareholder Derivative Action

Federman & Sherwood is pleased to announce that a settlement in a shareholder derivative action has been reached with Dynavax Technologies Corporation (NASDAQ: DVAX).

'Date' These Potential Biotech Winners

'Date' These Potential Biotech Winners

As with Adamas Pharmaceuticals, circling key milestone dates on your calendar can prove beneficial.

'Date' These Potential Biotech Winners

'Date' These Potential Biotech Winners

As with Adamas Pharmaceuticals, circling key milestone dates on your calendar can prove beneficial.

Small-Cap Turnaround Stories

Small-Cap Turnaround Stories

When one of these pays off, it can make up for a number of errant wagers.

Resist All the Dow 22K Hoopla: Cramer's 'Mad Money' Recap (Wednesday 8/2/17)

Resist All the Dow 22K Hoopla: Cramer's 'Mad Money' Recap (Wednesday 8/2/17)

Jim Cramer says investors should step away from these near-term shenanigans and focus on the fundamentals.

Chevron, Universal Display, Dynavax Technologies, Schlumberger: 'Mad Money' Lightning Round

Chevron, Universal Display, Dynavax Technologies, Schlumberger: 'Mad Money' Lightning Round

Jim Cramer is bullish on Chevron, Universal Display, Dynavax Technologies, and Schlumberger.

Dow's Big Day Ends With Record and Best Monthly Gain Since February

Dow's Big Day Ends With Record and Best Monthly Gain Since February

The Dow ends July with a bang.

Dow at Records, Rest of Market Retreats, in Close to Strong July

Dow at Records, Rest of Market Retreats, in Close to Strong July

Stocks are mixed.

The Stock Market Looks Like It Could End July With a Bang

The Stock Market Looks Like It Could End July With a Bang

Stock futures are higher.

Navigate Choppy Investment Waters With Good Trade Management

Navigate Choppy Investment Waters With Good Trade Management

The inconsistency makes stock picking difficult, but there are buying opportunities because of it.

September 15th Options Now Available For Dynavax Technologies (DVAX)

Investors in Dynavax Technologies Corp saw new options become available today, for the September 15th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the DVAX options chain for the new September 15th contracts and identified one put and one call contract of particular interest.

Interesting DVAX Call Options For July 21st

Investors in Dynavax Technologies Corp saw new options become available this week, for the July 21st expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the DVAX options chain for the new July 21st contracts and identified the following call contract of particular interest.

3 Biotech Stocks on Readers' Minds

3 Biotech Stocks on Readers' Minds

We answer questions about BioDelivery Sciences, Dynavax Technologies and Synergy Pharmaceuticals.

3 Small Biotechs on the FDA Summer Calendar

3 Small Biotechs on the FDA Summer Calendar

Dynavax Technologies, Ocular Therapeutix and Neos Therapeutics have big drug approval dates ahead.

TheStreet Quant Rating: D- (Sell)